Q4 2023 · 13F-HR
Redmile Group, LLCholdings as filed
Filed 2024-02-14 · accession 0001104659-24-023671
$2.80B
Reported value
70
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 45253H101 | IMGNEUR | IMMUNOGEN INC | $487.0M | 17.4% | 16,423,922 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $215.0M | 7.69% | 1,733,189 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $210.4M | 7.53% | 14,828,321 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $120.4M | 4.31% | 6,402,505 | Common | SOLE |
| 75525N107 | — | RAYZEBIO INC | $115.5M | 4.13% | 1,857,706 | Common | SOLE |
| 05105P107 | AUGX | AUGMEDIX INC | $95.8M | 3.43% | 16,380,327 | Common | SOLE |
| 24344T101 | DCPHEUR | DECIPHERA PHARMACEUTICALS IN | $77.4M | 2.77% | 4,801,540 | Common | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $67.7M | 2.42% | 142,500 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $67.5M | 2.41% | 3,760,690 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $61.8M | 2.21% | 1,444,365 | Common | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $60.2M | 2.15% | 5,790,230 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $58.8M | 2.10% | 1,137,068 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $54.5M | 1.95% | 3,659,264 | Common | SOLE |
| 148806102 | CTLTEUR | CATALENT INC | $49.4M | 1.77% | 1,100,466 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $49.3M | 1.76% | 13,169,057 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $48.8M | 1.75% | 2,696,648 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $46.4M | 1.66% | 1,823,956 | Common | SOLE |
| 45257U108 | IMNM | IMMUNOME INC | $41.5M | 1.48% | 3,879,415 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $41.2M | 1.47% | 977,072 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $40.1M | 1.43% | 693,200 | Common | SOLE |
| 82024L103 | STTK | SHATTUCK LABS INC | $40.1M | 1.43% | 5,619,914 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $39.4M | 1.41% | 993,803 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $38.9M | 1.39% | 1,429,783 | Common | SOLE |
| 00091E109 | ABSI | ABSCI CORPORATION | $33.7M | 1.21% | 8,031,094 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $33.6M | 1.20% | 3,256,519 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $33.3M | 1.19% | 935,863 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $32.6M | 1.17% | 3,865,258 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $31.2M | 1.12% | 1,374,189 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABS | $29.2M | 1.05% | 265,500 | Common | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC | $27.6M | 0.99% | 835,537 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $25.9M | 0.93% | 1,109,476 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $25.4M | 0.91% | 15,328,317 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $25.0M | 0.89% | 5,503,190 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIENCES INC | $24.7M | 0.88% | 2,971,542 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $24.0M | 0.86% | 1,718,669 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $24.0M | 0.86% | 95,242 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $22.0M | 0.79% | 1,969,402 | Common | SOLE |
| 159864107 | CRL | CHARLES RIV LABS INTL INC | $20.5M | 0.73% | 86,782 | Common | SOLE |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $19.4M | 0.69% | 1,283,735 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $18.4M | 0.66% | 946,897 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $18.3M | 0.65% | 54,258 | Common | SOLE |
| 40412C101 | HCA | HCA HEALTHCARE INC | $17.9M | 0.64% | 66,100 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $17.1M | 0.61% | 2,914,022 | Common | SOLE |
| 863667101 | SYK | STRYKER CORPORATION | $15.9M | 0.57% | 53,141 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $15.7M | 0.56% | 2,148,748 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $13.8M | 0.49% | 2,625,506 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $13.7M | 0.49% | 50,082 | Common | SOLE |
| 39868T105 | 2JQ | GRITSTONE BIO INC | $12.0M | 0.43% | 5,872,605 | Common | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $11.7M | 0.42% | 1,324,350 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $10.9M | 0.39% | 23,079 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $10.0M | 0.36% | 3,670,447 | Common | SOLE |
| H00263105 | ACIU | AC IMMUNE SA | $10.0M | 0.36% | 2,000,000 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $9.1M | 0.33% | 366,776 | Common | SOLE |
| 85916J409 | STXS | STEREOTAXIS INC | $6.0M | 0.21% | 3,402,443 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $5.7M | 0.20% | 1,440,725 | Common | SOLE |
| 808644207 | 6QV | SCIENCE 37 HOLDINGS INC | $5.3M | 0.19% | 990,412 | Common | SOLE |
| 046513107 | ATRAGBX | ATARA BIOTHERAPEUTICS INC | $4.7M | 0.17% | 9,106,446 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $4.6M | 0.16% | 3,031,009 | Common | SOLE |
| N51517105 | 4PKB | LAVA THERAPEUTICS NV | $3.3M | 0.12% | 2,074,372 | Common | SOLE |
| 58406B202 | MDVLQ | MEDAVAIL HOLDINGS INC | $3.1M | 0.11% | 692,082 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $2.5M | 0.09% | 1,046,587 | Common | SOLE |
| 00449L102 | 698 | ACHILLES THERAPEUTICS PLC | $1.4M | 0.05% | 1,608,089 | Common | SOLE |
| 019818103 | — | ALLOVIR INC | $1.3M | 0.05% | 1,907,969 | Common | SOLE |
| 83444K105 | SLGCUSD | SOMALOGIC INC | $938,223 | 0.03% | 370,839 | Common | SOLE |
| 46185L103 | NVTA1EUR | INVITAE CORP | $923,919 | 0.03% | 1,474,026 | Common | SOLE |
| 43906K100 | HOOKGBP | HOOKIPA PHARMA INC | $861,653 | 0.03% | 1,063,769 | Common | SOLE |
| 02080L102 | TKNO | ALPHA TEKNOVA INC | $600,549 | 0.02% | 161,005 | Common | SOLE |
| 00653A107 | ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | $567,476 | 0.02% | 715,607 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $511,791 | 0.02% | 207,203 | Common | SOLE |
| 04965G109 | BCELUSD | ATRECA INC | $58,430 | 0.00% | 442,653 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.